182 related articles for article (PubMed ID: 1898640)
1. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.
Henthorn RW; Waldo AL; Anderson JL; Gilbert EM; Alpert BL; Bhandari AK; Hawkinson RW; Pritchett EL
Circulation; 1991 Jan; 83(1):119-25. PubMed ID: 1898640
[TBL] [Abstract][Full Text] [Related]
2. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.
Bhandari AK; Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Cullen MT; Hawkinson RW; Pritchett EL
Am Heart J; 1992 Aug; 124(2):381-6. PubMed ID: 1636582
[TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
[TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
Dorian P; Naccarelli GV; Coumel P; Hohnloser SH; Maser MJ
Am J Cardiol; 1996 Jan; 77(3):89A-95A. PubMed ID: 8607397
[TBL] [Abstract][Full Text] [Related]
5. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
[TBL] [Abstract][Full Text] [Related]
6. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults.
Musto B; Cavallaro C; Musto A; D'Onofrio A; Belli A; De Vincentis L
Am Heart J; 1992 Jul; 124(1):110-5. PubMed ID: 1615792
[TBL] [Abstract][Full Text] [Related]
7. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Bhandari AK; Hawkinson RW; Pritchett EL
Circulation; 1989 Dec; 80(6):1557-70. PubMed ID: 2513143
[TBL] [Abstract][Full Text] [Related]
8. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
Pritchett EL; DaTorre SD; Platt ML; McCarville SE; Hougham AJ
J Am Coll Cardiol; 1991 Feb; 17(2):297-303. PubMed ID: 1899432
[TBL] [Abstract][Full Text] [Related]
9. Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group.
Anderson JL; Platt ML; Guarnieri T; Fox TL; Maser MJ; Pritchett EL
Am J Cardiol; 1994 Sep; 74(6):578-84. PubMed ID: 8074041
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo.
Tendera M; Wnuk-Wojnar AM; Kulakowski P; Malolepszy J; Kozlowski JW; Krzeminska-Pakula M; Szechinski J; Droszcz W; Kawecka-Jaszcz K; Swiatecka G; Ruzyllo W; Graff O
Am Heart J; 2001 Jul; 142(1):93-8. PubMed ID: 11431663
[TBL] [Abstract][Full Text] [Related]
11. Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias.
Wanless RS; Anderson K; Joy M; Joseph SP
Am Heart J; 1997 Apr; 133(4):441-6. PubMed ID: 9124166
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
Gambhir DS; Bhargava M; Arora R; Khalilullah M
Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
[TBL] [Abstract][Full Text] [Related]
13. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
Chimienti M; Cullen MT; Casadei G
Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
[TBL] [Abstract][Full Text] [Related]
14. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of propafenone and flecainide in a patient with reciprocating supraventricular tachycardia.
Montenero AS; Natale A; di Bona G; Calvi V; Santarelli P; Manzoli U
Cardiologia; 1990 Mar; 35(3):253-6. PubMed ID: 2123130
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response.
Page RL; Connolly SJ; Wilkinson WE; Marcello SR; Schnell DJ; Pritchett EL;
Am Heart J; 2002 Apr; 143(4):643-9. PubMed ID: 11923801
[TBL] [Abstract][Full Text] [Related]
17. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
DiMarco JP; Miles W; Akhtar M; Milstein S; Sharma AD; Platia E; McGovern B; Scheinman MM; Govier WC
Ann Intern Med; 1990 Jul; 113(2):104-10. PubMed ID: 2193560
[TBL] [Abstract][Full Text] [Related]
18. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial.
Stambler BS; Camm AJ; Alings M; Dorian P; Heidbuchel H; Houtgraaf J; Kowey PR; Merino JL; Mondésert B; Piccini JP; Pokorney SD; Sager PT; Verma A; Wharton JM; Bharucha DB; Plat F; Shardonofsky S; Chen M; Ip JE;
Lancet; 2023 Jul; 402(10396):118-128. PubMed ID: 37331368
[TBL] [Abstract][Full Text] [Related]
19. First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301).
Stambler BS; Plat F; Sager PT; Shardonofsky S; Wight D; Potvin D; Pandey AS; Ip JE; Coutu B; Mondésert B; Sterns LD; Bennett M; Anderson JL; Damle R; Haberman R; Camm AJ
Circ Arrhythm Electrophysiol; 2022 Dec; 15(12):e010915. PubMed ID: 36441560
[TBL] [Abstract][Full Text] [Related]
20. Flecainide acetate for long-term prevention of paroxysmal supraventricular tachyarrhythmias.
Benditt DG; Dunnigan A; Buetikofer J; Milstein S
Circulation; 1991 Jan; 83(1):345-9. PubMed ID: 1898643
[No Abstract] [Full Text] [Related]
[Next] [New Search]
